Improvement in Psoriasis Symptoms and Physical Functioning with Secukinumab Compared with Placebo and Etanercept in Subjects with Moderate-to-Severe Plaque Psoriasis and Psoriatic Arthritis: Results of a Subanalysis from the Phase 3 Fixture Study

被引：0
|
作者：
Gottlieb, Alice [1 ]
Langley, Richard [2 ]
Philipp, Sandra [3 ]
Martin, Ruvie [4 ]
Papavassilis, Charis [5 ]
Mpfofu, Shephard [5 ]
机构：
[1] Tufts Med Ctr, Boston, MA USA
[2] Dalhousie Univ, Halifax, NS, Canada
[3] Charite, D-13353 Berlin, Germany
[4] Novartis Pharma AG, East Hanover, Switzerland
[5] Novartis Pharma AG, Basel, Switzerland
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
L7
引用
收藏
页码：3322 / 3322
页数：1
相关论文
共 50 条
  • [1] Effect of secukinumab on psoriasis symptoms and physical functioning compared with placebo and etanercept in subjects with moderate-to-severe plaque psoriasis and concomitant psoriatic arthritis: a subanalysis from the phase 3 fixture study
    Sigurgeirsson, B.
    Gottlieb, A. B.
    Langley, R. G.
    Philipp, S.
    Martin, R. L. M.
    Papavassilis, C.
    Mpofu, S.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2014, 43 : 64 - 65
  • [2] Secukinumab effect on functional ability in subjects with moderate to severe plaque psoriasis and psoriatic arthritis: A subanalysis from the FIXTURE study
    Philipp, Sandra
    Papavassilis, Charis
    Notter, Marianne
    Fretzin, Scott
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB185 - AB185
  • [3] Secukinumab Shows Substantial Improvement In Both Psoriasis Symptoms and Physical Functioning In Moderate-To-Severe Plaque Psoriasis Patients With Psoriatic Arthritis: A Subanalysis Of a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study
    Gottlieb, Alice B.
    Sigurgeirsson, Bardur
    Blauvelt, Andrew
    Mpfofu, Shephard
    Martin, Ruvie
    Papavassilis, Charis
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S136 - S137
  • [4] Secukinumab efficacy in subjects with moderate-to-severe plaque psoriasis and concomitant psoriatic arthritis: A subanalysis of the ERASURE study
    Blauvelt, Andrew
    Gottlieb, Alice
    Sigurgeirsson, Bardur
    Papavassilis, Charis
    Martin, Ruvie
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB2 - AB2
  • [5] Secukinumab sustainability of response in subjects with moderate to severe plaque psoriasis: A subanalysis from the FIXTURE study
    Reich, Kristian
    Papavassilis, Charis
    Puig, Luis
    Notter, Marianne
    Draelos, Zoe
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB188 - AB188
  • [6] Secukinumab shows sustained response in subjects with moderate-to-severe plaque psoriasis: a subanalysis of the ERASURE phase 3 study
    Wylie, A.
    Lebwohl, M.
    Vender, R.
    Menter, A.
    Karpov, A.
    Papavassilis, C.
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2015, 56 : 83 - 83
  • [7] Improvement of psoriasis in subjects with and without psoriatic arthritis: Subanalysis of a brodalumab (AMG 827) phase 2 study for moderate to severe plaque psoriasis
    Papp, Kim
    Menter, Alan
    Strober, Bruce
    Milmont, Cassandra
    Ortonne, Jean-Paul
    Klekotka, Paul
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB172 - AB172
  • [8] Efficacy of secukinumab and adalimumab in psoriatic arthritis patients with moderate-to-severe plaque psoriasis: Results from the EXCEED study
    Gottlieb, Alice B.
    Merola, Joseph F.
    Reich, Kristian
    Behrens, Frank
    Nash, Peter
    Bao, Weibin
    Pellet, Pascale
    Pricop, Luminita
    McInnes, Iain B.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB92 - AB92
  • [9] Improvement of psoriasis in subjects with and without psoriatic arthritis: subanalysis of a brodalumab (AMG 827) phase 2 study for moderate to severe plaque psoriasis (PsO)
    Papp, K.
    Menter, A.
    Strober, B.
    Milmont, C. E.
    Klekotka, P.
    McQualter, R.
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2015, 56 : 51 - 52
  • [10] Maintenance regimen of secukinumab in subjects with moderate-to-severe plaque psoriasis: Results from the OPTIMISE study
    Reich, Kristian
    Puig, Lluis
    Szepietowski, Jacek C.
    Paul, Carle
    Lacour, Jean Philippe
    Tsianakas, Athanasios
    Sieder, Christian
    Rissler, Michael
    Jagiello, Piotr
    Orsenigo, Roberto
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB90 - AB90
12345